|
1
|
Nakao M, Yokota S, Iwai T, Kaneko H,
Horiike S, Kashima K, et al: Internal tandem duplication of the
flt3 gene found in acute myeloid leukemia. Leukemia. 10:1911–1918.
1996.PubMed/NCBI
|
|
2
|
Gambacorti-Passerini CB, Gunby RH, Piazza
R, Galietta A, Rostagno R and Scapozza L: Molecular mechanisms of
resistance to imatinib in Philadelphia-chromosome-positive
leukaemias. Lancet Oncol. 4:75–85. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paietta E, Ferrando AA, Neuberg D, et al:
Activating FLT3 mutations in CD117/KIT(+) T-cell acute
lymphoblastic leukemias. Blood. 104:558–560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yanada M, Takeuchi J, Sugiura I, et al:
High complete remission rate and promising outcome by combination
of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive
acute lymphoblastic leukemia: a phase II study by the Japan Adult
Leukemia Study Group. J Clin Oncol. 24:460–466. 2006. View Article : Google Scholar
|
|
5
|
Wang YY, Zhou GB, Yin T, et al: AML1-ETO
and C-KIT mutation/overexpression in t(8;21) leukemia: implication
in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad
Sci USA. 102:1104–1109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
George P, Bali P, Cohen P, et al:
Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3
kinase inhibitor PKC412 is highly effective against human acute
myelogenous leukemia cells with mutant FLT-3. Cancer Res.
64:3645–3652. 2004. View Article : Google Scholar
|
|
7
|
Kondoh T, Kobayashi D, Tsuji N,
Kuribayashi K and Watanabe N: Overexpression of serine threonine
tyrosine kinase 1/novel oncogene with kinase domain mRNA in
patients with acute leukemia. Exp Hematol. 37:824–830. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu L, Yu XZ, Li TS, et al: A novel
protein tyrosine kinase NOK that shares homology with
platelet-derived growth factor/fibroblast growth factor receptors
induces tumorigenesis and metastasis in nude mice. Cancer Res.
64:3491–3499. 2004. View Article : Google Scholar
|
|
9
|
Chen Y, Li YH, Chen XP, et al: Point
mutation at single tyrosine residue of novel oncogene NOK abrogates
tumorigenesis in nude mice. Cancer Res. 65:10838–10846. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma Y, Cui W, Yang J, et al: SALL4, a novel
oncogene, is constitutively expressed in human acute myeloid
leukemia (AML) and induces AML in transgenic mice. Blood.
108:2726–2735. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gupta R, Hong D, Iborra F, Sarno S and
Enver T: NOV (CCN3) functions as a regulator of human hematopoietic
stem or progenitor cells. Science. 316:590–593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeong HW, Cui W, Yang Y, Lu J, He J, Li A,
Song D, Guo Y, Liu BH and Chai L: SALL4, a stem cell factor,
affects the side population by regulation of the ATP-binding
cassette drug transport genes. PLoS One. 6:e183722011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bard JD, Gelebart P, Amin HM, Young LC, Ma
Y and Lai R: Signal transducer and activator of transcription 3 is
a transcriptional factor regulating the gene expression of SALL4.
FASEB J. 23:1405–1414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tazzari PL, Cappellini A, Ricci F, et al:
Multidrug resistance-associated protein 1 expression is under the
control of the phosphoinositide 3 kinase/Akt signal transduction
network in human acute myelogenous leukemia blasts. Leukemia.
21:427–438. 2007. View Article : Google Scholar
|
|
15
|
Chiarini F, Del Sole M, Mongiorgi S, et
al: The novel Akt inhibitor, perifosine, induces caspase-dependent
apoptosis and downregulates P-glycoprotein expression in
multidrug-resistant human T-acute leukemia cells by a JNK-dependent
mechanism. Leukemia. 22:1106–1116. 2008. View Article : Google Scholar
|
|
16
|
Moriai R, Kobayashi D, Amachika T, Tsuji N
and Watanabe N: Diagnostic relevance of overexpressed NOK mRNA in
breast cancer. Anticancer Res. 26:4969–4973. 2006.PubMed/NCBI
|
|
17
|
Amachika T, Kobayashi D, Moriai R, Tsuji N
and Watanabe N: Diagnostic relevance of overexpressed mRNA of novel
oncogene with kinase-domain (NOK) in lung cancers. Lung Cancer.
56:337–340. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harbott J, Viehmann S, Borkhardt A, Henze
G and Lampert F: Incidence of TEL/AML1 fusion gene analyzed
consecutively in children with acute lymphoblastic leukemia in
relapse. Blood. 90:4933–4937. 1997.PubMed/NCBI
|
